Bayer to invest $3.2 million in Guatemala
The Bayer Central America and the Caribbean Group will invest in remodeling their Consumer Care Division factory.
Wednesday, November 19, 2008
Located on Roosevelt Road, it is where they produce over-the-counter (OTC) medications such as Alka-Seltzer, Tabcín, Cafiaspirina and Alive, to name a few.
Before the end of the year, the multinational corporation will inaugurate an extension of to its medicine production facility in Mixco.
Bayer has invested $5.1 million in its plant in Guatemala in order to increase production by 10%.
VIJOSA laboratories has started construction of a plant for producing medicines in an area of 9 blocks in Santa Tecla, department of La Libertad.
The company's plans contemplate investing another $8 million in a plant located in Ilopango and exporting to South America.
- Daily Update
- Government Purchases
- Classified Ads
- Indexes & Statistics
- Press Releases
- Events Calendar